SCYX Q2 2022 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1M

Gross Profit

$1M89.1% margin

Operating Income

-$22M-1643.1% margin

Net Income

-$13M-1008.7% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+92.6%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$136M

Total Liabilities

$90M

Stockholders' Equity

$45M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$22M	-$18M	-24.2%
Net Income	-$13M	$2M	-904.9%

Revenue Segments

Product

$1M100%